Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT05147077 Recruiting - Anxiety Clinical Trials

Integrated Rehabilitation in Treating Post-stroke Anxiety

IRTPA
Start date: January 24, 2022
Phase: N/A
Study type: Interventional

Post-stroke anxiety (PSA) is a common complication of stroke that leads to dysfunction and reduces the quality of life. PSA exacerbates cognitive dysfunction, delays the recovery process, and increases the disability, mortality, and recurrence rates of stroke. Therefore, early clinical treatments for PSA are important to improve the prognosis and restore the social functions of stroke patients. Integrated rehabilitation has significant advantages in the treatment of PSA. First of all, there is a wide range of rehabilitation methods, such as acupuncture, traditional Chinese medicine, and repetitive transcranial magnetic stimulation, which have been proved to be effective for PSA. However, as the application of integrated rehabilitation becomes more and more widespread, its shortcomings are gradually emerging. For example, most of the treatment protocols used in clinical studies are based on personal experience of the investigators, a unified protocol has not yet been formed, treatment methods are still insufficient in standardization and reproducibility. More studies focus solely on the improvement of a certain symptom by a certain rehabilitation therapy, but ignore the important theoretical basis of the "holistic concept", thus showing the uneven clinical efficacy. For the above existing problems, it is necessary to conduct original and innovative research.

NCT ID: NCT05146765 Completed - Clinical trials for Dysarthria as Late Effect of Stroke

Efficacy of a Digital Therapeutic for People With Dysarthria After Stroke

Start date: January 18, 2022
Phase: N/A
Study type: Interventional

This pilot trial will establish the feasibility of a new digitized speech rehabilitation developed for patients with post-stroke dysarthria. For this study, participants will be instructed to use the speech therapy app for 30 minutes to 1 hour per day over a 4-week period.

NCT ID: NCT05146037 Recruiting - Stroke Clinical Trials

INTERvention With Cerebral Embolic Protection in Transcatheter Aortic Valve Implantation (INTERCEPTavi)

INTERCEPTavi
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The study aims to evaluate the processes of a pilot single-centre randomised controlled trial (RCT) of carbon-dioxide flushing of transcatheter aortic valves (TAVI-CO2) versus standard saline flushing of valves (TAVI-S) and assess potential neuroprotection through a number of neurological endpoints for planning of a full-sized RCT

NCT ID: NCT05145699 Recruiting - Clinical trials for Stroke, Complication

A Pilot Study on the Feasibility Study of a Novel Virtual Reality (VR)-Based Post-stroke Hemineglect Evaluation System

Start date: August 31, 2021
Phase: N/A
Study type: Interventional

The normal value of the new virtual reality (VR)-based hemineglect evaluation system is obtained and its validity is checked by whether there is a difference in the evaluation results between normal people, stroke patients with hemineglect, and stroke patients without hemineglect. And, the usability of the virtual reality-based hemineglect evaluation system is confirmed.

NCT ID: NCT05144958 Recruiting - Stroke Clinical Trials

Stand-alone Left Atrial Appendage Occlusion for Thromboembolism Prevention

SALAMANDER
Start date: March 1, 2019
Phase:
Study type: Observational [Patient Registry]

This prospective nationwide registry aims to assess the durability of left atrial appendage occlusion when performed via totally thoracoscopic, percutaneous and hybrid- minimally invasive approaches and collect information on possible adverse events.

NCT ID: NCT05144932 Recruiting - Stroke Clinical Trials

StrokeAlarm Trial 2

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This open, multicenter, prospective, singel-arm study will evaluate usability and feasibility of a wearable stroke indication system (Stroke Alarm) in patients with recent TIA, recent minor stroke without persistent arm motor deficit, or atrial fibrillation up to 1 month.

NCT ID: NCT05143385 Active, not recruiting - Stroke, Acute Clinical Trials

Efficacy of Recreational-therapeutic Use of Video Games on the Emotional State of Stroke Patients

Start date: October 11, 2021
Phase: N/A
Study type: Interventional

According to the latest published literature reviews, stroke patients have a prevalence of 19.5% of minor depression and 21.7% of major depression. Furthermore, the loss of autonomy is the most strongly correlated variable in these emotional disorders. In addition, emotional disturbances - in particular anxiety, sadness, crying, and anhedonia - are interpreted as natural reactions to the loss of physical capacity. Along these lines, it has been shown that the use of Virtual Reality (VR) as a co-adjuvant therapy of neuro-rehabilitation in stroke patients with emotional disorders decreases the incidence of these disorders.

NCT ID: NCT05142917 Completed - Stroke Clinical Trials

The Effect of tDCS Based on Functional Brain Imaging for Subacute Stroke Patients

Start date: February 11, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether brain imaging-based hand function area tDCS stimulation is more effective than conventional stimulation or sham stimulation for improving hand motor function.

NCT ID: NCT05142163 Completed - Clinical trials for Goal Directed Fluid Therapy

Stroke Volume Variation and Plethysmography Variability Index as Goal Directed Fluid Therapy in Major Oncosurgeries

SVV PVI GDFT
Start date: November 8, 2021
Phase: N/A
Study type: Interventional

Patients were allotted to two Groups , SVV Guided Fluid Therapy Group received intraoperative fluids to maintain SVV <11 , and PVI Guided Group received intraoperative Fluids to maintain PVI<11

NCT ID: NCT05141695 Recruiting - Stroke Clinical Trials

Evaluation of the Effect of Repetitive Peripheral Magnetic Stimulation on Upper Extremity Spasticity After Stroke

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Spasticity is a frequent problem in post-stroke patients. It can negatively affect the functional recovery of patients and impair their quality of life. The repetitive pulsed magnetic stimulation (rPMS) treatment has been shown to cause a reduction in muscle tone and improvement in activities of daily living in stroke patients. So far, the effects of rPMS on muscle tone, which is the neurophysiological component of spasticity, have been evaluated, but its effects on the biomechanical component (soft tissue stiffness) have not been demonstrated. In this study, the effects of rPMS on soft tissue stiffness as well as increased muscle tone will be evaluated with clinical and ultrasound elastography in post-stroke patients with upper extremity spasticity.